14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $6.22 $6.22 Friday, 27th Jan 2023 LJPC stock ended at $6.22. During the day the stock fluctuated 0% from a day low at $6.22 to a day high of $6.22.
90 days $6.22 $6.22
52 weeks $3.07 $6.24

Historical La Jolla Pharmaceutical Company prices

Date Open High Low Close Volume
Jan 27, 2023 $6.22 $6.22 $6.22 $6.22 0
Jan 26, 2023 $6.22 $6.22 $6.22 $6.22 0
Jan 25, 2023 $6.22 $6.22 $6.22 $6.22 0
Jan 24, 2023 $6.22 $6.22 $6.22 $6.22 0
Jan 23, 2023 $6.22 $6.22 $6.22 $6.22 0
Jan 20, 2023 $6.22 $6.22 $6.22 $6.22 0
Jan 19, 2023 $6.22 $6.22 $6.22 $6.22 0
Jan 18, 2023 $6.22 $6.22 $6.22 $6.22 0
Jan 17, 2023 $6.22 $6.22 $6.22 $6.22 0
Jan 13, 2023 $6.22 $6.22 $6.22 $6.22 0
Jan 12, 2023 $6.22 $6.22 $6.22 $6.22 0
Jan 11, 2023 $6.22 $6.22 $6.22 $6.22 0
Jan 10, 2023 $6.22 $6.22 $6.22 $6.22 0
Jan 09, 2023 $6.22 $6.22 $6.22 $6.22 0
Jan 06, 2023 $6.22 $6.22 $6.22 $6.22 0
Jan 05, 2023 $6.22 $6.22 $6.22 $6.22 0
Jan 04, 2023 $6.22 $6.22 $6.22 $6.22 0
Jan 03, 2023 $6.22 $6.22 $6.22 $6.22 0
Dec 30, 2022 $6.22 $6.22 $6.22 $6.22 0
Dec 29, 2022 $6.22 $6.22 $6.22 $6.22 0
Dec 28, 2022 $6.22 $6.22 $6.22 $6.22 0
Dec 27, 2022 $6.22 $6.22 $6.22 $6.22 0
Dec 23, 2022 $6.22 $6.22 $6.22 $6.22 0
Dec 22, 2022 $6.22 $6.22 $6.22 $6.22 0
Dec 21, 2022 $6.22 $6.22 $6.22 $6.22 0
Click to get the best stock tips daily for free!

About La Jolla Pharmaceutical Company

La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age ... LJPC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT